Unitedhealth Group Inc [UNH] stock is trading at $309.87, up 2.51%. An important factor to consider is whether the stock is rising or falling in short-term value. The UNH shares have gain 0.80% over the last week, with a monthly amount glided 24.17%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Unitedhealth Group Inc [NYSE: UNH] stock has seen the most recent analyst activity on July 31, 2025, when Robert W. Baird downgraded its rating to a Underperform but kept the price target unchanged to $198 for it. Previously, Oppenheimer reaffirmed its Outperform rating on July 30, 2025, and dropped its price target to $325. On June 11, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $312 on the stock. HSBC Securities downgraded its rating to a Reduce but stick to its price target of $270 on May 21, 2025. TD Cowen downgraded its rating to a Hold but $308 remained the price target by the analyst firm on May 19, 2025. Raymond James downgraded its rating to Mkt Perform for this stock on May 14, 2025. In a note dated May 14, 2025, BofA Securities downgraded a Neutral rating on this stock but restated the target price of $350.
Unitedhealth Group Inc [UNH] stock has fluctuated between $234.60 and $630.73 over the past year. Currently, Wall Street analysts expect the stock to reach $357.4 within the next 12 months. Unitedhealth Group Inc [NYSE: UNH] shares were valued at $309.87 at the most recent close of the market. An investor can expect a potential return of 15.34% based on the average UNH price forecast.
Analyzing the UNH fundamentals
Unitedhealth Group Inc [NYSE:UNH] reported sales of 422.82B for the trailing twelve months, which represents a growth of 12.91%. Gross Profit Margin for this corporation currently stands at 0.21% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.22 and Total Capital is 0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 303.85 points at the first support level, and at 297.84 for the second support level. However, for the 1st resistance point, the stock is sitting at 312.94, and for the 2nd resistance point, it is at 316.02.
Ratios To Look Out For
For context, Unitedhealth Group Inc’s Current Ratio is 0.85. Considering the valuation of this stock, the price to sales ratio is 0.66, the price to book ratio is 2.96 and price to earnings (TTM) ratio is 13.42.
Transactions by insiders
Recent insider trading involved Conway Patrick Hugh, Chief Executive Officer, Optum, that happened on Jun 10 ’25 when 589.0 shares were sold. Officer, Conway Patrick Hugh completed a deal on Jun 10 ’25 to buy 589.0 shares. Meanwhile, President & CFO REX JOHN F bought 17175.0 shares on May 16 ’25.
